About
ECM Therapeutics is advancing regenerative medicine through a natural biomaterial that restores nature’s original blueprint to treat disease and injury. Its FDA-cleared ECM scaffolds have been used in over 10 million patients to repair tissues across musculoskeletal, cardiovascular, and skin systems. Building on this success, the company’s patented ECM hydrogel technology enables less invasive applications across multiple diseases, with its first clinical product, EsophaGel, developed to treat Barrett’s esophagus — a precancerous condition with no current effective therapy.
Warrendale